Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | 35,153,000 | 17,941,000 | 20,878,000 | 14,714,000 | 15,119,000 |
Depreciation Amortization | 7,486,000 | 6,970,000 | 7,390,000 | 7,231,000 | 7,009,000 |
Income taxes - deferred | -4,194,000 | -1,663,000 | -2,079,000 | -1,141,000 | -2,476,000 |
Accounts receivable | -624,000 | -1,307,000 | -2,450,000 | 837,000 | -309,000 |
Other Working Capital | 2,507,000 | -4,028,000 | -4,286,000 | 2,753,000 | 3,845,000 |
Other Operating Activity | -17,537,000 | 3,281,000 | 3,957,000 | -858,000 | 228,000 |
Operating Cash Flow | $22,791,000 | $21,194,000 | $23,410,000 | $23,536,000 | $23,416,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -4,185,000 | -3,466,000 | -2,941,000 | -3,042,000 | -233,000 |
Net Acquisitions | N/A | -17,652,000 | -60,000 | -7,323,000 | -5,810,000 |
Purchase Of Investment | -10,906,000 | -32,384,000 | -30,394,000 | -21,089,000 | -3,920,000 |
Sale Of Investment | 19,390,000 | 41,609,000 | 25,006,000 | 12,137,000 | 3,387,000 |
Other Investing Activity | -3,421,000 | -478,000 | -294,000 | -1,508,000 | 382,000 |
Investing Cash Flow | $878,000 | $-12,371,000 | $-8,683,000 | $-20,825,000 | $-6,194,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 21,790,000 | 16,134,000 | 1,997,000 | 3,391,000 | 39,000 |
Debt Issued | 0 | 2,000 | 5,000 | 7,431,000 | 3,000 |
Debt Repayment | -1,551,000 | -2,134,000 | -1,802,000 | -1,064,000 | -2,823,000 |
Common Stock Issued | 5,335,000 | 1,329,000 | 1,036,000 | 1,114,000 | 954,000 |
Common Stock Repurchased | -5,054,000 | -6,035,000 | -3,456,000 | -3,221,000 | -6,746,000 |
Dividend Paid | -11,770,000 | -11,682,000 | -11,032,000 | -10,481,000 | -9,917,000 |
Other Financing Activity | -24,575,000 | -6,485,000 | -795,000 | -3,290,000 | 475,000 |
Financing Cash Flow | $-15,825,000 | $-8,871,000 | $-14,047,000 | $-6,120,000 | $-18,015,000 |
Exchange Rate Effect | -112,000 | -312,000 | -178,000 | 89,000 | -9,000 |
Beginning Cash Position | 14,127,000 | 14,487,000 | 13,985,000 | 17,305,000 | 18,107,000 |
End Cash Position | 21,859,000 | 14,127,000 | 14,487,000 | 13,985,000 | 17,305,000 |
Net Cash Flow | $7,732,000 | $-360,000 | $502,000 | $-3,320,000 | $-802,000 |
Free Cash Flow | |||||
Operating Cash Flow | 22,791,000 | 21,194,000 | 23,410,000 | 23,536,000 | 23,416,000 |
Capital Expenditure | -4,543,000 | -4,009,000 | -3,652,000 | -3,347,000 | -3,498,000 |
Free Cash Flow | 18,248,000 | 17,185,000 | 19,758,000 | 20,189,000 | 19,918,000 |